Chemical Compound

MRS 1754

CAS Registry Number 264622-58-4
MRS 1754 chemical structure
Primary Record

MRS 1754

In stock
9,688 g
Purity
99.3 %
CAS
264622-58-4

Compound Identifiers & Properties

CAS
264622-58-4
PubChem CID
6603931
SMILES
CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)OCC(=O)NC4=CC=C(C=C4)C#N
Canonical SMILES
CCCn1c(=O)c2[nH]c(-c3ccc(OCC(=O)Nc4ccc(C#N)cc4)cc3)nc2n(CCC)c1=O

Names & Synonyms

  • MRS 1754
  • MRS1754
  • 264622-58-4
  • MRS-1754
  • RefChem:827519
  • 7E435V2DAH
  • Lopac-M-6316
  • D01QYQ
  • D0NE5P
  • ATL-GW-8
  • CHEMBL273807
  • UNII-7E435V2DAH
  • Lopac0_000729
  • GTPL449
  • GTPL453
  • ATL-GW-22
  • MLS002153324
  • DTXSID80424967
  • AC1O7G54
  • orb1308009
  • SCHEMBL1222380
  • SCHEMBL3395773
  • CHEMBL1628266
  • [3H]MRS1754
  • CHEBI:93269
  • CTK8E7916
  • AOB5542
  • ATL-618
  • ATL-844
  • DTXCID00375801
  • [3H]-MRS1754
  • AJBBEYXFRYFVNM-UHFFFAOYSA-N
  • C26H26N6O4
  • GLXC-06634
  • HMS2230A06
  • HMS3268F13
  • HMS3373J21
  • HMS3742I17
  • BCP31360
  • EX-A7320
  • MRS1754?
  • PKA62258
  • ZINC4475274
  • BDBM50086170
  • MFCD09971130
  • NCGC00015689-01
  • s6693
  • N-(4-Cyanophenyl)-2-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)phenoxy)acetamide
  • AKOS024457276
  • CCG-204814
  • CID6603931
  • EX-3306
  • CID:6603931
  • MRS-1754; MRS 1754
  • NCGC00015689-02
  • NCGC00015689-03
  • NCGC00015689-04
  • NCGC00094075-01
  • NCGC00094075-02
  • NCGC00094075-03
  • AS-80780
  • DA-75755
  • HY-14121
  • SMR001230737
  • SID:181285846
  • N-(4-cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamide
  • B7173
  • CS-0003210
  • EU-0100729
  • J1.293.769E
  • 8-[4-[( oxy]phenyl]-1,3-di xanthinehydrate
  • G13686
  • M 6316
  • C423842
  • L000415
  • SR-01000076213
  • A1010179
  • N-(4-Cyanophenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-acetamide
  • SR-01000076213-1
  • BRD-K72024482-001-01-3
  • Q27087766
  • Acetamide, N-(4-cyanophenyl)-2-[4-(2,3,6,9-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-
  • A2B adenosine receptor antagonists, Adenosine/Ortho-McNeil
  • N-(4-cyanophenyl)-2-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy)acetamide
  • A2B adenosine receptor antagonists (oral, asthma/diabetes), Clinical Data
  • Acetamide, N-(4-cyanophenyl)-2-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy)-
  • Acetamide, N-(4-cyanophenyl)-2-(4-(2,3,6,9-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy)-
  • N-(4-cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy]acetamide
  • 8-(4-(((4-cyanophenyl)carbamoylmethyl)oxy)phenyl)-1,3-di(ni-propyl)xanthine
  • 8-[4-[((4-Cyanophenyl)carbamoylmethyl)oxy]phenyl]-1,3-di(n-propyl)xanthine
  • 8-[4-[((4-Cyanophenyl)carbamoylmethyl)oxy]phenyl]-1,3-di(n-propyl)xanthine hydrate
  • A2B adenosine receptor antagonists (oral, asthma/diabetes), Adenosine Therapeutics
  • N-(4-cyanophenyl)-2-(4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy)acetamide
  • N-(4-cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-9H-purin-8-yl)phenoxy]acetamide
  • (4-Cyano-phenyl)-carbamic acid 4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-phenyl ester
  • Acetamide,N-(4-cyanophenyl)-2-[4-(2,3,6,9-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-
  • N-(4-Cyano-phenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-phenoxy]-acetamide
  • N-(4-Cyano-phenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-phenoxy]-acetamide(MRS-1754)
  • N-(4-cyanophenyl)-2-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-phenoxy)acetamide
  • N-(4-Cyanophenyl)-2-[4-(1,3-dipropyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purine-8-yl)phenoxy]acetamide
  • N-(4-Cyanophenyl)-2-[4-(1,3-dipropyl-2,6-dioxo-3,7-dihydro-1H-purine-8-yl)phenoxy]acetamide